List view / Grid view
18 October 2018 | By Iqra Farooq (European Pharmaceutical Review)
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion...
18 October 2018 | By Gilson
Chromatographic purification of natural compounds presents many challenges to scientists because of the complex nature of the starting matrices that are used in the process...
4 October 2018 | By Peak Scientific
Peak Scientific, a global leader in gas generation for analytical laboratories, has recently partnered with Ontario-based Molecular Science Corp. (MSC) to supply nitrogen gas generation systems on their first mobile laboratory aimed at the rapidly expanding cannabis testing and research sector...
28 June 2018 | By European Pharmaceutical Review
The FDA has approved Epidiolex oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy...
24 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
12 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
29 June 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A study has confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
Follow: